Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the first half of 2016
Date: 2017-02-23
Institutions: Standing Committee of the EFTA States
Subjects: EFTA countries, free movement of goods, market approval, medicinal product, withdrawal from the market








C_2017058EN.01001001.xml










23.2.2017   


EN


Official Journal of the European Union


C 58/10





Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the first half of 2016
(2017/C 58/08)

Subcommittee I on the free movement of goods


To be noted by the EEA Joint Committee

With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 January-30 June 2016, at their meeting on 28 October 2016:







Annex I



List of new marketing authorisations





Annex II



List of renewed marketing authorisations





Annex III



List of extended marketing authorisations





Annex IV



List of withdrawn marketing authorisations





Annex V



List of suspended marketing authorisations






ANNEX I
List of new marketing authorisations
The following marketing authorisations have been granted in the EEA EFTA States during the period 1 January-30 June 2016:








EU-Number


Product


Country


Date of authorisation




EU/1/15/1053


Neofordex


Liechtenstein


30.4.2016




EU/1/15/1053


Neofordex


Iceland


31.3.2016




EU/1/15/1053


Neofordex


Norway


1.4.2016




EU/1/15/1063


Pemetrexed Actavis


Liechtenstein


29.2.2016




EU/1/15/1063


Pemetrexed Actavis


Norway


25.1.2016




EU/1/15/1063


Pemetrexed Actavis


Iceland


25.1.2016




EU/1/15/1064


Imlygic


Liechtenstein


29.2.2016




EU/1/15/1064


Imlygic


Norway


20.1.2016




EU/1/15/1064


Imlygic


Iceland


14.1.2016




EU/1/15/1065


Eptifibatid Accord


Liechtenstein


29.2.2016




EU/1/15/1065


Eptifibatide Accord


Norway


18.1.2016




EU/1/15/1065


Eptifibatide Accord


Iceland


14.1.2016




EU/1/15/1066


Ongentys


Liechtenstein


30.6.2016




EU/1/15/1067


Lopinavir/Ritonavir Mylan


Liechtenstein


29.2.2016




EU/1/15/1067


Lopinavir/Ritonavir Mylan


Norway


21.1.2016




EU/1/15/1067


Lopinavir/Ritonavir Mylan


Iceland


20.1.2016




EU/1/15/1068


Wakix


Liechtenstein


30.4.2016




EU/1/15/1068


Wakix


Norway


19.4.2016




EU/1/15/1068


Wakix


Iceland


22.4.2016




EU/1/15/1069


Episalvan


Liechtenstein


29.2.2016




EU/1/15/1069


Episalvan


Norway


20.1.2016




EU/1/15/1069


Episalvan


Iceland


19.1.2016




EU/1/15/1070


Oncaspar


Liechtenstein


29.2.2016




EU/1/15/1070


Oncaspar


Norway


25.1.2016




EU/1/15/1070


Oncaspar


Iceland


25.1.2016




EU/1/15/1071


Pemetrexed Accord


Liechtenstein


29.2.2016




EU/1/15/1071


Pemetrexed Accord


Norway


25.1.2016




EU/1/15/1071


Pemetrexed Accord


Iceland


25.1.2016




EU/1/15/1072


Spectrila


Liechtenstein


29.2.2016




EU/1/15/1072


Spectrila


Norway


19.1.2016




EU/1/15/1072


Spectrila


Iceland


19.1.2016




EU/1/15/1073


Briviact


Liechtenstein


29.2.2016




EU/1/15/1073


Briviact


Norway


21.1.2016




EU/1/15/1073


Briviact


Iceland


25.1.2016




EU/1/15/1074


Benepali


Liechtenstein


29.2.2016




EU/1/15/1074


Benepali


Norway


19.1.2016




EU/1/15/1074


Benepali


Iceland


19.1.2016




EU/1/15/1075


Feraccru


Liechtenstein


29.2.2016




EU/1/15/1075


Feraccru


Norway


7.3.2016




EU/1/15/1075


Feraccru


Iceland


18.3.2016




EU/1/15/1076


Kovaltry


Liechtenstein


29.2.2016




EU/1/15/1076


Kovaltry


Norway


10.3.2016




EU/1/15/1076


Kovaltry


Iceland


16.3.2016




EU/1/15/1077


Iblias


Liechtenstein


29.2.2016




EU/1/15/1077


Iblias


Norway


10.3.2016




EU/1/15/1077


Iblias


Iceland


16.3.2016




EU/1/15/1079


Vaxelis


Liechtenstein


29.2.2016




EU/1/15/1079


Vaxelis


Norway


29.2.2016




EU/1/15/1079


Vaxelis


Iceland


1.3.2016




EU/1/15/1080


Zurampic


Liechtenstein


29.2.2016




EU/1/15/1080


Zurampic


Norway


3.3.2016




EU/1/15/1080


Zurampic


Iceland


16.3.2016




EU/1/15/1081


Caspofungin Accord


Liechtenstein


29.2.2016




EU/1/15/1081


Caspofungin Accord


Norway


29.2.2016




EU/1/15/1081


Caspofungin Accord


Iceland


25.2.2016




EU/1/15/1082


Galafold


Liechtenstein


30.6.2016




EU/1/15/1082


Galafold


Norway


14.6.2016




EU/1/15/1082


Galafold


Iceland


14.6.2016




EU/1/15/1083


Uptravi


Liechtenstein


30.6.2016




EU/1/15/1083


Uptravi


Iceland


26.5.2016




EU/1/15/1083


Uptravi


Norway


30.5.2016




EU/1/15/1084


Portrazza


Liechtenstein


29.2.2016




EU/1/15/1084


Portrazza


Norway


26.2.2016




EU/1/15/1084


Portrazza


Iceland


15.3.2016




EU/1/15/1085


Taltz


Liechtenstein


30.4.2016




EU/1/15/1085


Taltz


Norway


9.5.2016




EU/1/15/1085


Taltz


Iceland


20.5.2016




EU/1/16/1086


Tagrisso


Liechtenstein


29.2.2016




EU/1/16/1086


Tagrisso


Norway


19.2.2016




EU/1/16/1086


Tagrisso


Iceland


11.2.2016




EU/1/16/1087


Coagadex


Liechtenstein


30.4.2016




EU/1/16/1087


Coagadex


Norway


1.4.2016




EU/1/16/1087


Coagadex


Iceland


22.3.2016




EU/1/16/1088


Empliciti


Liechtenstein


30.6.2016




EU/1/16/1088


Empliciti


Norway


24.5.2016




EU/1/16/1088


Empliciti


Iceland


19.5.2016




EU/1/16/1089


Pandemic influenza vaccine H5N1 MedImmune


Liechtenstein


30.6.2016




EU/1/16/1089


Pandemic influenza vaccine H5N1 MedImmune


Norway


30.5.2016




EU/1/16/1089


Pandemic influenza vaccine H5N1 MedImmune


Iceland


30.5.2016




EU/1/16/1090


Rasagiline Mylan


Liechtenstein


30.4.2016




EU/1/16/1090


Rasagiline Mylan


Norway


19.4.2016




EU/1/16/1090


Rasagiline Mylan


Iceland


22.4.2016




EU/1/16/1092


Amlodipin/Valsartan Mylan


Liechtenstein


30.4.2016




EU/1/16/1092


Amlodipine/Valsartan Mylan


Norway


11.4.2016




EU/1/16/1092


Amlodipine/Valsartan Mylan


Iceland


31.3.2016




EU/1/16/1093


Zonisamide Mylan


Liechtenstein


30.4.2016




EU/1/16/1093


Zonisamide Mylan


Norway


19.4.2016




EU/1/16/1093


Zonisamide Mylan


Iceland


22.4.2016




EU/1/16/1095


Idelvion


Liechtenstein


30.6.2016




EU/1/16/1095


Idelvion


Norway


30.5.2016




EU/1/16/1095


Idelvion


Iceland


23.5.2016




EU/1/16/1096


Lonsurf


Liechtenstein


30.4.2016




EU/1/16/1096


Lonsurf


Norway


9.5.2016




EU/1/16/1096


Lonsurf


Iceland


20.5.2016




EU/1/16/1097


Strimvelis


Liechtenstein


30.6.2016




EU/1/16/1097


Strimvelis


Norway


9.6.2016




EU/1/16/1097


Strimvelis


Iceland


16.6.2016




EU/1/16/1098


Alprolix


Liechtenstein


30.6.2016




EU/1/16/1098


Alprolix


Norway


25.5.2016




EU/1/16/1098


Alprolix


Iceland


20.5.2016




EU/1/16/1099


Descovy


Liechtenstein


30.4.2016




EU/1/16/1099


Descovy


Norway


27.4.2016




EU/1/16/1099


Descovy


Iceland


18.5.2016




EU/1/16/1100


Palonosetron Hospira


Liechtenstein


30.4.2016




EU/1/16/1100


Palonosetron Hospira


Norway


19.4.2016




EU/1/16/1100


Palonosetron Hospira


Iceland


27.4.2016




EU/1/16/1101


Darzalex


Liechtenstein


30.6.2016




EU/1/16/1101


Darzalex


Norway


30.5.2016




EU/1/16/1101


Darzalex


Iceland


30.5.2016




EU/1/16/1103


Neparvis


Liechtenstein


30.6.2016




EU/1/16/1103


Neparvis


Norway


24.6.2016




EU/1/16/1104


Palonosetron Accord


Liechtenstein


30.6.2016




EU/1/16/1104


Palonosteron Accord


Norway


14.6.2016




EU/1/16/1104


Palonosetron Accord


Iceland


14.6.2016




EU/1/16/1106


Flixabi


Liechtenstein


30.6.2016




EU/1/16/1106


Flixabi


Norway


17.6.2016




EU/1/16/1106


Flixabi


Iceland


15.6.2016




EU/1/16/1109


Zavicefta


Liechtenstein


30.6.2016




EU/1/16/1112


Odefsey


Liechtenstein


30.6.2016




EU/1/16/1112


Odefsey


Norway


24.6.2016




EU/2/15/192


Velactis


Norway


4.1.2016




EU/2/15/193


Imrestor


Norway


5.1.2016




EU/2/15/193


Imrestor


Iceland


4.1.2016




EU/2/16/194


Evalon


Liechtenstein


30.4.2016




EU/2/16/194


Evalon


Norway


11.5.2016




EU/2/16/194


Evalon


Iceland


13.5.2016




EU/2/16/195


Letifend


Liechtenstein


30.4.2016




EU/2/16/195


Letifend


Norway


27.4.2016




EU/2/16/195


Letifend


Iceland


18.5.2016







ANNEX II
List of renewed marketing authorisations
The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 January-30 June 2016:








EU-Number


Product


Country


Date of authorisation




EU/1/05/323


ProQuad


Iceland


4.1.2016




EU/1/05/323


ProQuad


Norway


11.1.2016




EU/1/05/330


Rotarix


Liechtenstein


29.2.2016




EU/1/05/330


Rotarix


Iceland


20.1.2016




EU/1/05/330


Rotarix


Norway


20.1.2016




EU/1/05/331


Neupro


Liechtenstein


29.2.2016




EU/1/05/331


Neupro


Iceland


28.1.2016




EU/1/05/331


Neupro


Norway


4.2.2016




EU/1/06/334


Evoltra


Liechtenstein


29.2.2016




EU/1/06/334


Evoltra


Norway


19.1.2016




EU/1/06/334


Evoltra


Iceland


20.1.2016




EU/1/06/336


Tygacil


Liechtenstein


29.2.2016




EU/1/06/336


Tygacil


Norway


18.3.2016




EU/1/06/336


Tygacil


Iceland


18.3.2016




EU/1/06/341


Zostavax


Liechtenstein


29.2.2016




EU/1/06/341


Zostavax


Norway


29.2.2016




EU/1/06/341


Zostavax


Iceland


18.2.2016




EU/1/06/346


Tysabri


Norway


29.4.2016




EU/1/06/346


Tysabri


Iceland


12.5.2016




EU/1/06/354


Competact


Liechtenstein


30.4.2016




EU/1/06/354


Competact


Norway


12.5.2016




EU/1/06/354


Competact


Iceland


18.5.2016




EU/1/06/356


Exjade


Liechtenstein


30.4.2016




EU/1/06/356


Exjade


Norway


2.5.2016




EU/1/06/356


Exjade


Iceland


12.5.2016




EU/1/09/543


Cayston


Liechtenstein


30.6.2016




EU/1/09/543


Cayston


Norway


14.6.2016




EU/1/09/543


Cayston


Iceland


13.6.2016




EU/1/10/652


TOBI Podhaler


Liechtenstein


29.2.2016




EU/1/10/652


TOBI Podhaler


Norway


1.3.2016




EU/1/10/652


TOBI Podhaler


Iceland


17.3.2016




EU/1/11/671


Xiapex


Liechtenstein


29.2.2016




EU/1/11/671


Xiapex


Norway


25.1.2016




EU/1/11/671


Xiapex


Iceland


27.1.2016




EU/1/11/672


Xeplion


Norway


11.1.2016




EU/1/11/672


Xeplion


Iceland


4.1.2016




EU/1/11/674


Repso


Liechtenstein


29.2.2016




EU/1/11/674


Repso


Norway


25.1.2016




EU/1/11/674


Repso


Iceland


20.1.2016




EU/1/11/679


Pravafenix


Liechtenstein


29.2.2016




EU/1/11/679


Pravafenix


Norway


2.2.2016




EU/1/11/679


Pravafenix


Iceland


26.1.2016




EU/1/11/681


Trobalt


Liechtenstein


29.2.2016




EU/1/11/681


Trobalt


Norway


25.1.2016




EU/1/11/681


Trobalt


Iceland


26.1.2016




EU/1/11/682


Methylthioninium chloride Proveblue


Norway


29.2.2016




EU/1/11/682


Methylthioninium chloride Proveblue


Iceland


16.2.2016




EU/1/11/682


Methylthioniniumchlorid Proveblue


Liechtenstein


29.2.2016




EU/1/11/685


Ibandronic acid Sandoz


Norway


11.5.2016




EU/1/11/685


Ibandronic acid Sandoz


Iceland


27.4.2016




EU/1/11/687


Hizentra


Liechtenstein


29.2.2016




EU/1/11/687


Hizentra


Norway


29.2.2016




EU/1/11/687


Hizentra


Iceland


17.3.2016




EU/1/11/688


Cinryze


Liechtenstein


30.6.2016




EU/1/11/688


Cinryze


Norway


22.6.2016




EU/1/11/688


Cinryze


Iceland


13.6.2016




EU/1/11/690


Zoely


Liechtenstein


30.4.2016




EU/1/11/690


Zoely


Norway


29.4.2016




EU/1/11/690


Zoely


Iceland


18.5.2016




EU/1/11/691


Eliquis


Liechtenstein


29.2.2016




EU/1/11/691


Eliquis


Norway


2.2.2016




EU/1/11/691


Eliquis


Iceland


26.1.2016




EU/1/11/692


Yellox


Liechtenstein


29.2.2016




EU/1/11/692


Yellox


Norway


2.2.2016




EU/1/11/692


Yellox


Iceland


19.1.2016




EU/1/11/693


Rivastigmin Actavis


Norway


3.3.2016




EU/1/11/693


Rivastigmine Actavis


Liechtenstein


29.2.2016




EU/1/11/693


Rivastigmine Actavis


Iceland


15.3.2016




EU/1/11/694


Nulojix


Liechtenstein


29.2.2016




EU/1/11/694


Nulojix


Norway


26.2.2016




EU/1/11/694


Nulojix


Iceland


17.3.2016




EU/1/11/695


Leganto


Liechtenstein


29.2.2016




EU/1/11/695


Leganto


Norway


1.2.2016




EU/1/11/695


Leganto


Iceland


26.1.2016




EU/1/11/696


Bydureon


Liechtenstein


29.2.2016




EU/1/11/696


Bydureon


Norway


10.3.2016




EU/1/11/696


Bydureon


Iceland


17.3.2016




EU/1/11/697


Temozolomide SUN


Liechtenstein


30.4.2016




EU/1/11/697


Temozolomide SUN


Norway


29.4.2016




EU/1/11/697


Temozolomide SUN


Iceland


18.5.2016




EU/1/11/698


Yervoy


Liechtenstein


30.4.2016




EU/1/11/698


Yervoy


Norway


29.4.2016




EU/1/11/698


Yervoy


Iceland


18.5.2016




EU/1/11/699


Fampyra


Liechtenstein


30.6.2016




EU/1/11/699


Fampyra


Iceland


15.6.2016




EU/1/11/700


Benlysta


Liechtenstein


29.2.2016




EU/1/11/700


Benlysta


Norway


26.2.2016




EU/1/11/700


Benlysta


Iceland


18.3.2016




EU/1/11/702


Levetiracetam ratiopharm


Liechtenstein


30.4.2016




EU/1/11/702


Levetiracetam ratiopharm


Norway


18.5.2016




EU/1/11/702


Levetiracetam ratiopharm


Iceland


19.5.2016




EU/1/11/703


Xgeva


Liechtenstein


30.6.2016




EU/1/11/703


Xgeva


Norway


18.5.2016




EU/1/11/703


Xgeva


Iceland


13.5.2016




EU/1/11/704


Victrelis


Liechtenstein


29.2.2016




EU/1/11/704


Victrelis


Iceland


17.3.2016




EU/1/11/704


Victrelis


Norway


3.3.2016




EU/1/11/705


Vibativ


Liechtenstein


30.6.2016




EU/1/11/705


Vibativ


Iceland


13.6.2016




EU/1/11/705


Vibativ


Norway


9.6.2016




EU/1/11/706


Levodopa/Carbidopa/Entacapone Orion


Liechtenstein


30.6.2016




EU/1/11/706


Levodopa/Carbidopa/Entacapone Orion


Iceland


15.6.2016




EU/1/11/707


Trajenta


Liechtenstein


30.4.2016




EU/1/11/707


Trajenta


Norway


19.4.2016




EU/1/11/707


Trajenta


Iceland


31.3.2016




EU/1/11/708


Entacapone Orion


Liechtenstein


30.4.2016




EU/1/11/708


Entacapone Orion


Norway


21.4.2016




EU/1/11/708


Entacapone Orion


Iceland


26.4.2016




EU/1/11/709


Buccolam


Liechtenstein


30.6.2016




EU/1/11/709


Buccolam


Norway


24.6.2016




EU/1/11/709


Buccolam


Iceland


13.6.2016




EU/1/11/714


Zytiga


Liechtenstein


30.6.2016




EU/1/11/714


Zytiga


Norway


14.6.2016




EU/1/11/714


Zytiga


Iceland


13.6.2016




EU/1/11/718


Dexdor


Liechtenstein


30.6.2016




EU/1/11/718


Dexdor


Norway


20.6.2016




EU/1/11/718


Dexdor


Iceland


13.6.2016




EU/1/11/719


Telmisartan Teva Pharma


Liechtenstein


30.6.2016




EU/1/11/719


Telmisartan Teva Pharma


Norway


23.6.2016




EU/1/11/749


Caprelsa


Norway


14.1.2016




EU/1/11/749


Caprelsa


Iceland


14.1.2016




EU/1/12/764


Pixuvri


Liechtenstein


30.4.2016




EU/1/12/764


Pixuvri


Norway


1.4.2016




EU/1/12/764


Pixuvri


Iceland


31.3.2016




EU/1/13/818


Bosulif


Norway


14.1.2016




EU/1/13/818


Bosulif


Iceland


13.1.2016




EU/1/13/848


Erivedge


Norway


16.6.2016




EU/1/13/848


Erivedge


Iceland


15.6.2016




EU/1/13/875


Deltyba


Norway


29.3.2016




EU/1/13/875


Deltyba


Iceland


22.3.2016




EU/1/13/890


Cometriq


Liechtenstein


29.2.2016




EU/1/13/890


Cometriq


Norway


20.1.2016




EU/1/13/890


Cometriq


Iceland


19.1.2016




EU/1/13/901


Sirturo


Liechtenstein


29.2.2016




EU/1/13/901


Sirturo


Norway


14.1.2016




EU/1/13/901


Sirturo


Iceland


13.1.2016




EU/1/14/987


Holoclar


Iceland


4.1.2016




EU/1/15/999


Zykadia


Liechtenstein


30.4.2016




EU/1/15/999


Zykadia


Norway


6.4.2016




EU/1/15/999


Zykadia


Iceland


31.3.2016




EU/2/06/061


Nobilis Influenza H5N2


Norway


28.6.2016




EU/2/10/107


Veraflox


Liechtenstein


29.2.2016




EU/2/10/107


Veraflox


Norway


13.1.2016




EU/2/10/107


Veraflox


Iceland


15.1.2016




EU/2/10/115


Comfortis


Liechtenstein


29.2.2016




EU/2/10/115


Comfortis


Norway


18.1.2016




EU/2/10/115


Comfortis


Iceland


15.1.2016




EU/2/10/116


Melosus


Liechtenstein


29.2.2016




EU/2/10/116


Melosus


Norway


22.1.2016




EU/2/10/116


Melosus


Iceland


22.1.2016




EU/2/10/118


Activyl


Liechtenstein


29.2.2016




EU/2/10/118


Activyl


Norway


29.1.2016




EU/2/10/118


Activyl


Iceland


15.1.2016




EU/2/10/119


Cimalgex


Liechtenstein


29.2.2016




EU/2/10/119


Cimalgex


Norway


19.1.2016




EU/2/10/119


Cimalgex


Iceland


15.1.2016




EU/2/11/120


Zulvac 1 + 8 Ovis


Liechtenstein


29.2.2016




EU/2/11/120


Zulvac 1 + 8 Ovis


Norway


19.1.2016




EU/2/11/120


Zulvac 1 + 8 Ovis


Iceland


15.1.2016




EU/2/11/121


CaniLeish


Liechtenstein


29.2.2016




EU/2/11/121


CaniLeish


Norway


18.1.2016




EU/2/11/121


CaniLeish


Iceland


15.1.2016




EU/2/11/122


Bluevac BTV8


Liechtenstein


30.4.2016




EU/2/11/122


Bluevac BTV8


Norway


29.3.2016




EU/2/11/122


Bluevac BTV8


Iceland


29.3.2016




EU/2/11/123


Procox


Liechtenstein


29.2.2016




EU/2/11/123


Procox


Norway


20.1.2016




EU/2/11/123


Procox


Iceland


20.1.2016




EU/2/11/124


Zuprevo


Liechtenstein


30.6.2016




EU/2/11/124


Zuprevo


Norway


1.6.2016




EU/2/11/124


Zuprevo


Iceland


26.5.2016




EU/2/11/125


Certifect


Liechtenstein


30.4.2016




EU/2/11/125


Certifect


Norway


4.5.2016




EU/2/11/125


Certifect


Iceland


12.5.2016




EU/2/11/126


MS-H Impfstoff


Liechtenstein


30.6.2016




EU/2/11/126


MS-H Vaccine


Iceland


23.5.2016




EU/2/11/126


MS-H-Vaksine


Norway


24.5.2016




EU/2/11/128


Emdocam


Liechtenstein


30.6.2016




EU/2/11/128


Emdocam


Norway


27.6.2016




EU/2/11/129


Proteq West Nile


Liechtenstein


30.6.2016




EU/2/11/129


Proteq West Nile


Norway


24.5.2016




EU/2/11/129


Proteq West Nile


Iceland


23.5.2016




EU/2/11/130


Zulvac 1 Bovis


Liechtenstein


30.4.2016




EU/2/11/130


Zulvac 1 Bovis


Norway


2.5.2016




EU/2/11/130


Zulvac 1 Bovis


Iceland


13.5.2016




EU/2/11/131


Zulvac 1 Ovis


Liechtenstein


30.4.2016




EU/2/11/131


Zulvac 1 Ovis


Norway


2.5.2016




EU/2/11/131


Zulvac 1 Ovis


Iceland


13.5.2016







ANNEX III
List of extended marketing authorisations
The following marketing authorisations have been extended in the EEA EFTA States during the period 1 January-30 June 2016:








EU-Number


Product


Country


Date of authorisation




EU/1/03/262/011


Emend


Norway


15.1.2016




EU/1/03/262/011


Emend


Iceland


14.1.2016




EU/1/06/356/011-019


Exjade


Norway


1.4.2016




EU/1/06/356/011-019


Exjade


Iceland


31.3.2016




EU/1/10/612/010-013


Revolade


Norway


14.4.2016




EU/1/10/612/010-013


Revolade


Iceland


26.4.2016




EU/1/10/655/007-011


Brilique


Norway


26.2.2016




EU/1/10/655/007-011


Brilique


Iceland


18.3.2016




EU/1/13/851/004-006


Lojuxta


Norway


1.3.2016




EU/1/13/851/004-006


Lojuxta


Iceland


18.3.2016




EU/1/14/971/007-010


Trevicta


Norway


7.6.2016




EU/1/14/971/007-010


Trevicta


Iceland


15.6.2016




EU/1/98/067/004


Mabthera


Iceland


15.6.2016




EU/1/98/067/004


Mabthera


Norway


26.5.2016




EU/2/13/158/016-031


Bravecto


Norway


7.6.2016




EU/2/13/158/016-031


Bravecto


Iceland


25.5.2016







ANNEX IV
List of withdrawn marketing authorisations
The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 January-30 June 2016:








EU-Number


Product


Country


Date of withdrawal




EU/1/01/179


Osigraft


Norway


18.1.2016




EU/1/01/179


Osigraft


Iceland


4.1.2016




EU/1/05/314


Kepivance


Liechtenstein


30.4.2016




EU/1/05/314


Kepivance


Iceland


29.3.2016




EU/1/05/314


Kepivance


Norway


22.3.2016




EU/1/13/831


Capecitabin SUN


Liechtenstein


30.6.2016




EU/1/13/833


Nuedexta


Liechtenstein


30.4.2016




EU/1/13/833


Nuedexta


Norway


31.3.2016




EU/1/13/833


Nuedexta


Iceland


21.3.2016




EU/1/14/942


Clopidogrel/Acetylsalicylic acid Teva


Norway


15.6.2016




EU/2/12/138


RevitaCAM


Liechtenstein


30.6.2016




EU/2/12/138


RevitaCAM


Norway


15.6.2016




EU/2/12/138


RevitaCAM


Iceland


13.6.2016







ANNEX V
List of suspended marketing authorisations
The following marketing authorisations have been suspended in the EEA EFTA States during the period 1 January-30 June 2016:








EU-Number


Product


Country


Date of suspension